Status:

COMPLETED

Clinical Development of Deep Learning for the OtoSight

Lead Sponsor:

PhotoniCare, Inc.

Collaborating Sponsors:

University of Pittsburgh

National Institute on Deafness and Other Communication Disorders (NIDCD)

Conditions:

Otitis Media Acute

Eligibility:

All Genders

6-4 years

Brief Summary

The objective of this study is to clinically develop and evaluate a machine learning approach to improve the performance and data interpretation of the PhotoniCare OtoSight Middle Ear Scope in pediatr...

Eligibility Criteria

Inclusion

  • Pediatric patients presenting for an office visit with ear-related complaints

Exclusion

  • Otoscopy contra-indicated or not possible per attending clinician's decision, Down's syndrome (due to abnormalities in ear canal anatomy)

Key Trial Info

Start Date :

January 19 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 31 2023

Estimated Enrollment :

188 Patients enrolled

Trial Details

Trial ID

NCT04722770

Start Date

January 19 2021

End Date

August 31 2023

Last Update

January 23 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Children's Hospital of Pittsburgh

Pittsburgh, Pennsylvania, United States, 15213

Clinical Development of Deep Learning for the OtoSight | DecenTrialz